Subtotal Gastrectomy

These approaches provide different ways to restore gastrointestinal continuity after the diseased portion is removed. Reconstruction may connect the remaining stomach with the duodenum or the jejunum, depending on the approach used. The selected pathway determines how food passes through the altered gastrointestinal tract and is therefore central to postoperative digestive function and clinical follow-up.

Even when gastric tissue remains, the operation reduces stomach capacity and changes the normal route and handling of food. These alterations can influence digestion and nutrient absorption, creating a need for dietary adjustment and clinical monitoring. The changed anatomy also helps explain why patients may experience weight loss, anemia, or other postgastrectomy syndromes.

The procedure may be selected for gastric cancers and other serious stomach disorders when removing affected tissue is clinically appropriate. Resection can also relieve obstruction or bleeding caused by the underlying gastric problem. Its role therefore combines disease control with symptom relief, while the extent of surgery must preserve enough stomach for reconstruction and ongoing function.

Follow-up serves two distinct purposes: detecting recurrence of the original disease and identifying consequences of the altered stomach. Surveillance can therefore include attention to nutritional status, weight changes, anemia, and postgastrectomy syndromes, in addition to disease monitoring. Continued assessment helps clinicians recognize problems that may emerge after the immediate surgical recovery period.

The operation first removes the diseased portion of the stomach while preserving the remaining gastric tissue. The surgeon then restores gastrointestinal continuity by connecting the gastric remnant to the duodenum or jejunum through a Billroth I, Billroth II, or Roux-en-Y reconstruction. Subsequent care includes dietary adjustment and monitoring for nutritional or postgastrectomy complications.

Dietary adjustment is an important part of care because the remaining stomach has reduced capacity and the reconstructed pathway can alter digestion and nutrient absorption. Clinical monitoring should focus on weight loss and anemia as potential indicators of nutritional difficulty. Individual management is guided by the patient’s recovery and ongoing findings rather than by the operation alone.

Clinicians may consider this operation when disease is confined to a portion of the stomach or when a serious gastric disorder requires removal of affected tissue, based on the clinical situation. In addition to treating selected gastric cancers, resection can relieve obstruction or bleeding. The decision also requires planning for reconstruction and long-term postoperative surveillance.

Follow-up should evaluate both the intended clinical benefit and changes produced by surgery. Relief of obstruction or bleeding may be an important outcome when those problems prompted treatment, while recurrence surveillance remains relevant for gastric cancer. Clinicians also monitor for weight loss, anemia, altered nutrient absorption, and postgastrectomy syndromes as possible complications.